Clinical Trial Update: Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of furosemide on ESWL outcomes in patients with urinary tract stones is in progress; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis
• Ureterolithiasis
• Urinary Calculi
• Urolithiasis

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Urolithiasis, Nephrolithiasis | Phase 3 | Status: UNKNOWN